Assessment of myocardial viability using cardiac magnetic resonance feature tracking at rest and during low-dose dobutamine stress: a comparison with delayed gadolinium enhancement
摘要
Accurate assessment of myocardial viability is crucial for guiding treatment decisions in patients with ischemic cardiomyopathy (ICM). Delayed gadolinium enhancement (DGE) is the current gold standard, but non-contrast methods like feature tracking (FT) analysis during dobutamine stress are emerging. This work evaluates the efficiency of myocardial viability assessment using cardiac magnetic resonance feature tracking (CMR-FT) during stress by low-dose dobutamine.
MethodsThis retrospective case-control study enrolled 50 ICM patients who underwent CMR at rest and during low-dose dobutamine stress. FT analysis was performed to assess circumferential, radial, and longitudinal strain at both rest and stress. DGE was used as reference to determine viability.
ResultsSignificant strain improvement with dobutamine was observed in segments deemed viable by DGE, while non-viable segments showed no improvement.
ConclusionCMR-FT during low-dose dobutamine stress shows promise as non-contrast method for assessing myocardial viability in ICM patients, providing a potential alternative to DGE.